Are antibodies against La (SSB) no longer useful for the diagnosis of Sjögren's syndrome?

Spoerl, David; Roux-Lombard, Pascale

Scientific article

Letter

English

Are antibodies against La (SSB) no longer useful for the diagnosis of Sjögren's syndrome?

ContributorsSpoerl, David; Roux-Lombard, Pascale

Published inClinical and Experimental Rheumatology, vol. 37 Suppl 118, no. 3, p. 252-253

Publication date2019

Abstract

A case of severe cutaneous haemorrhage due to thrombocytopenia in combination with an acquired haemophilia A is reported. The thrombocytopenia was due to acute myelomonocytic leukaemia (FAB M4). A factor VIII:C specific anticoagulant was also found. Chemotherapy led to complete remission with normal blood counts and coagulation-test results.

Keywords

Antibodies
Antinuclear/immunology
Autoantigens
Humans
Sjogren's Syndrome/diagnosis/immunology

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Etude de l'activation des monocytes/macrophages et des polynucléaires neutrophiles (779)

Citation (ISO format)

SPOERL, David, ROUX-LOMBARD, Pascale. Are antibodies against La (SSB) no longer useful for the diagnosis of Sjögren’s syndrome? In: Clinical and Experimental Rheumatology, 2019, vol. 37 Suppl 118, n° 3, p. 252–253.

Article (Published version)

Identifiers

PID : unige:128494
PMID : 30943135

Journal ISSN0392-856X

263views

1downloads

Creation04/11/2019 17:54:00

First validation04/11/2019 17:54:00

Update15/03/2023 18:40:12

Status update15/03/2023 18:40:12

Last indexation31/10/2024 17:28:31

Archive ouverte UNIGE

Are antibodies against La (SSB) no longer useful for the diagnosis of Sjögren's syndrome?

Technical informations